A quarterly publication of the Autism Research Institute

The Autism Research Review International is quarterly publication of the Autism Research Institute

Winter, 2017 | Number 1, Volume 31

Animal study hints that resveratrol may reduce symptoms in ASD

A new study suggests that resveratrol, an antioxidant found in grapes and berries, may be a beneficial treatment for autism spectrum disorders (ASD). 

Ranjana Bhandari and colleagues infused propanoic acid (PPA) into the brains of male rats to create a mouse model of ASD. The PPAexposed rats exhibited autistic-like symptoms including abnormal social interactions, stereotyped behaviors, anxiety, depression, sensorimotor problems, hyperactivity, and learning and memory issues. In addition, they showed evidence of oxidative stress, mitochondrial dysfunction, and neuroinflammation. 

The researchers administered resveratrol to three groups of the rats in different daily doses (5, 10, and 15 mg/kg), with a fourth group serving as controls. They report, “Treatment with resveratrol for four weeks restored, significantly and dose-dependently, all the neurological, sensory, behavioral, biochemical, and molecular deficits in PPA-induced autistic phenotype in rats.” They conclude that resveratrol “ has strong potential to be explored clinically as an adjunct therapeutic agent for mitigating the neurobehavioral, biochemical and molecular alterations in ASD.”


Citations

“Resveratrol suppresses neuroinflammation in the experimental paradigm of autism spectrum disorders,” Ranjana Bhandari and Anurag Kuhad, Neurochemistry International, December 23, 2016 (epub ahead of print publication). Address: Ranjana Bhandari, [email protected].